Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-F D C Limited
F D C Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:531599NSE:FDCBloomberg:FDCLT@INReuters:FDC.BO
Market Lot: 1Face Value: 1ISIN Demat: INE258B01022
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
FDC, formerly FairDeal Corporation, is engaged in bulk drugs, formulations and food products. It has a presence in numerous therapeutic segments such as anti-infectives, dermatologicals, respiratory, haematinics and ophthalmics. Its plant in Roha manufactures pharma dosage forms, food products and bulk drugs for anti-rheumatic, anti-asthmatics, opthalmic and ENT segments. These bulk drugs are either exported (more than 80% of the production) or...   More..
Future Plans
One To One
Recent news
Latest News
FDC climbs on buyback news   -IRIS 22-Aug-12
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 2171.698308.537608.57
Other Income153.78381.64475.61
Total Income2325.478690.178084.18
Cost of goods sold1750.736306.345820.76
OPBDIT574.742383.832263.42
PAT343.011344.201583.32
Gross Block---
Equity capital177.83177.83180.83
EPS (Rs.)-7.548.68
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-10.48 - 19.038.64 - 12.21
Debt / Equity (x)---
Operating margin (% of OI)24.727.428.0
Net margin (% of OI)14.815.519.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
B-8, M I D C Industrial Estate
District Waluj
Aurangabad
Maharashtra-431 136
PHONE
(0240) 2554 407/ 2554 967
FAX
(0240) 2554 299
 
Board of Directors
Board Meetings
Date Purpose
12-NOV-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer